InvestorsHub Logo
Followers 0
Posts 17
Boards Moderated 0
Alias Born 01/26/2024

Re: powerwalker post# 291

Sunday, 01/26/2025 9:20:28 AM

Sunday, January 26, 2025 9:20:28 AM

Post# of 342
For 2025, Stan Druckenmiller
made his long pick in the Robin Hood contest in Verona Pharma (VRNA). Verona's inhaled treatment for adults with chronic obstructive pulmonary disease (COPD) won FDA approval last June. On Jan. 8, it said fourth-quarter sales totaled $36 million in the multi-billion dollar blockbuster indication.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VRNA News